BD installs production hub in Zaraogza
BD will build a €165m manufacturing facility in Zaragoza, Spain to support the growth of its pre-filled drug delivery business.
The new plant that is set to produce drug delivery devices is expected to start be fully operational by 2030. The €165m high-tech manufacturing facility in Zaragoza, located in the Aragon region of Spain, will create up to 600 jobs
BD said it plans to begin construction of its fourth plant in Spain in late 2021. BD’s new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs, said Eric Borin, worldwide president of BD Pharmaceutical Systems. This new plant will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the COVID-19 pandemic.
The new site represents a portion of the $1.2bn investment over four years that BD announced in December 2020 to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) as part of BD’s 2025 growth strategy.
T. Rowe Price
Sandoz
Tenthpin Solutions AG